ENZN
Price:
$0.04683
Market Cap:
$3.48M
Enzon Pharmaceuticals, Inc., together with its subsidiaries, engages in marketing drug products. The company's marketed drug product is PegIntron. It also has a marketing agreement relating to Vicineum drug. The company was founded in 1981 and is headquartered in Cranford, New Jersey.
Industry
Biotechnology
IPO Date
1984-02-15
Stock Exchange
OTC
Ticker
ENZN
According to Enzon Pharmaceuticals, Inc.’s latest financial reports and current stock price. The company's current ROE is -65.33%. This represents a change of 4.87% compared to the average of -62.30% of the last 4 quarters.
The mean historical ROE of Enzon Pharmaceuticals, Inc. over the last ten years is 21.30%. The current -65.33% ROE has changed -406.67% with respect to the historical average. Over the past ten years (40 quarters), ENZN's ROE was at its highest in in the December 2015 quarter at 69.09%. The ROE was at its lowest in in the June 2025 quarter at -229.17%.
Average
21.30%
Median
-0.10%
Minimum
-16.17%
Maximum
119.61%
Discovering the peaks and valleys of Enzon Pharmaceuticals, Inc. ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 12.04%
Maximum Annual ROE = 119.61%
Minimum Annual Increase = -646.34%
Minimum Annual ROE = -16.17%
| Year | ROE | Change |
|---|---|---|
| 2024 | 25.86% | 12.04% |
| 2023 | 0.21% | -152.58% |
| 2022 | -0.41% | -59.08% |
| 2021 | -0.99% | -63.87% |
| 2020 | -2.74% | -83.04% |
| 2019 | -16.17% | -141.45% |
| 2018 | 39.01% | -34.49% |
| 2017 | 59.55% | -646.34% |
| 2016 | -10.90% | -109.11% |
| 2015 | 119.61% | 22.97% |
The current ROE of Enzon Pharmaceuticals, Inc. (ENZN) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages
3-year avg
8.56%
5-year avg
4.39%
10-year avg
21.30%
Enzon Pharmaceuticals, Inc.’s ROE is greater than Core One Labs Inc. (-289.95%), less than Evolutionary Genomics, Inc. (161.33%), greater than Sorrento Therapeutics, Inc. (-1904.94%), greater than Telo Genomics Corp. (-298.52%), less than Sigyn Therapeutics, Inc. (76.84%), greater than Doseology Sciences Inc. (-34.11%), greater than Canntab Therapeutics Limited (-376.90%), less than HealthLynked Corp. (87.87%), less than Futura Medical plc (15.42%), less than LFTD Partners Inc. (0.16%),
| Company | ROE | Market cap |
|---|---|---|
| -289.95% | $22.14K | |
| 161.33% | $1.33K | |
| -1904.94% | $1.91M | |
| -298.52% | $3.21M | |
| 76.84% | $1.78M | |
| -34.11% | $232.23K | |
| -376.90% | $3.89K | |
| 87.87% | $4.30M | |
| 15.42% | $6.10M | |
| 0.16% | $2.96M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Enzon Pharmaceuticals, Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Enzon Pharmaceuticals, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the ROE?
How can you use the ROE?
What is Enzon Pharmaceuticals, Inc.'s ROE?
How is the ROE calculated for Enzon Pharmaceuticals, Inc. (ENZN)?
What is the highest ROE for Enzon Pharmaceuticals, Inc. (ENZN)?
What is the 3-year average ROE for Enzon Pharmaceuticals, Inc. (ENZN)?
What is the 5-year average ROE for Enzon Pharmaceuticals, Inc. (ENZN)?
How does the current ROE for Enzon Pharmaceuticals, Inc. (ENZN) compare to its historical average?